vs

Side-by-side financial comparison of FENNEC PHARMACEUTICALS INC. (FENC) and Forge Global Holdings, Inc. (FRGE). Click either name above to swap in a different company.

Forge Global Holdings, Inc. is the larger business by last-quarter revenue ($21.3M vs $13.8M, roughly 1.5× FENNEC PHARMACEUTICALS INC.). FENNEC PHARMACEUTICALS INC. runs the higher net margin — -34.7% vs -85.7%, a 51.0% gap on every dollar of revenue. On growth, FENNEC PHARMACEUTICALS INC. posted the faster year-over-year revenue change (73.8% vs 10.6%). Over the past eight quarters, Forge Global Holdings, Inc.'s revenue compounded faster (5.6% CAGR vs -26.3%).

Fennec Pharmaceuticals Inc. is a biopharmaceutical firm focused on developing and commercializing therapies to reduce treatment-related side effects in pediatric cancer patients. Its lead product targets chemotherapy-induced ototoxicity, with core North American markets serving oncology providers and vulnerable pediatric patient groups.

Bharat Forge Limited is an Indian multinational company involved in forging, automotives, energy, construction and mining, railways, marine, aerospace and defence industries.

FENC vs FRGE — Head-to-Head

Bigger by revenue
FRGE
FRGE
1.5× larger
FRGE
$21.3M
$13.8M
FENC
Growing faster (revenue YoY)
FENC
FENC
+63.2% gap
FENC
73.8%
10.6%
FRGE
Higher net margin
FENC
FENC
51.0% more per $
FENC
-34.7%
-85.7%
FRGE
Faster 2-yr revenue CAGR
FRGE
FRGE
Annualised
FRGE
5.6%
-26.3%
FENC

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
FENC
FENC
FRGE
FRGE
Revenue
$13.8M
$21.3M
Net Profit
$-4.8M
$-18.2M
Gross Margin
98.6%
Operating Margin
-18.5%
-96.7%
Net Margin
-34.7%
-85.7%
Revenue YoY
73.8%
10.6%
Net Profit YoY
-141.1%
0.6%
EPS (diluted)
$-0.17
$-1.37

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FENC
FENC
FRGE
FRGE
Q4 25
$13.8M
Q3 25
$12.5M
$21.3M
Q2 25
$9.7M
$27.7M
Q1 25
$8.8M
$25.3M
Q4 24
$7.9M
$18.6M
Q3 24
$7.0M
$19.2M
Q2 24
$7.3M
$22.3M
Q1 24
$25.4M
$19.2M
Net Profit
FENC
FENC
FRGE
FRGE
Q4 25
$-4.8M
Q3 25
$-638.0K
$-18.2M
Q2 25
$-3.2M
$-12.6M
Q1 25
$-1.2M
$-16.2M
Q4 24
$-2.0M
$-15.6M
Q3 24
$-5.7M
$-18.3M
Q2 24
$-5.6M
$-13.7M
Q1 24
$12.8M
$-18.6M
Gross Margin
FENC
FENC
FRGE
FRGE
Q4 25
Q3 25
98.6%
Q2 25
99.4%
Q1 25
99.2%
Q4 24
98.3%
Q3 24
99.6%
Q2 24
98.9%
Q1 24
99.8%
Operating Margin
FENC
FENC
FRGE
FRGE
Q4 25
-18.5%
Q3 25
-1.5%
-96.7%
Q2 25
-28.3%
-46.3%
Q1 25
-9.2%
-65.1%
Q4 24
-11.8%
-100.6%
Q3 24
-74.6%
-108.8%
Q2 24
-69.4%
-79.2%
Q1 24
54.2%
-130.0%
Net Margin
FENC
FENC
FRGE
FRGE
Q4 25
-34.7%
Q3 25
-5.1%
-85.7%
Q2 25
-32.7%
-45.4%
Q1 25
-13.3%
-63.9%
Q4 24
-25.0%
-84.2%
Q3 24
-82.2%
-95.5%
Q2 24
-76.5%
-61.6%
Q1 24
50.6%
-96.8%
EPS (diluted)
FENC
FENC
FRGE
FRGE
Q4 25
$-0.17
Q3 25
$-0.02
$-1.37
Q2 25
$-0.11
$-1.01
Q1 25
$-0.04
$-1.29
Q4 24
$-0.02
$3.81
Q3 24
$-0.21
$-1.49
Q2 24
$-0.20
$-1.13
Q1 24
$0.41
$-1.55

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FENC
FENC
FRGE
FRGE
Cash + ST InvestmentsLiquidity on hand
$36.8M
$60.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$35.5M
$202.6M
Total Assets
$70.6M
$252.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FENC
FENC
FRGE
FRGE
Q4 25
$36.8M
Q3 25
$21.9M
$60.7M
Q2 25
$18.7M
$80.7M
Q1 25
$22.7M
$92.0M
Q4 24
$26.6M
$105.1M
Q3 24
$40.3M
$114.5M
Q2 24
$43.1M
$120.5M
Q1 24
$51.2M
$129.6M
Total Debt
FENC
FENC
FRGE
FRGE
Q4 25
Q3 25
$19.4M
Q2 25
$19.4M
Q1 25
$19.4M
Q4 24
$19.3M
Q3 24
$32.1M
Q2 24
$31.8M
Q1 24
$31.3M
Stockholders' Equity
FENC
FENC
FRGE
FRGE
Q4 25
$35.5M
Q3 25
$-4.5M
$202.6M
Q2 25
$-7.5M
$200.5M
Q1 25
$-5.9M
$213.5M
Q4 24
$-5.9M
$223.6M
Q3 24
$-5.2M
$234.5M
Q2 24
$-1.4M
$245.4M
Q1 24
$3.0M
$252.2M
Total Assets
FENC
FENC
FRGE
FRGE
Q4 25
$70.6M
Q3 25
$49.3M
$252.0M
Q2 25
$44.9M
$242.8M
Q1 25
$46.4M
$249.5M
Q4 24
$44.9M
$263.5M
Q3 24
$58.9M
$276.6M
Q2 24
$63.2M
$285.7M
Q1 24
$69.2M
$298.7M
Debt / Equity
FENC
FENC
FRGE
FRGE
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
10.40×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FENC
FENC
FRGE
FRGE
Operating Cash FlowLast quarter
$-6.0M
$-11.4M
Free Cash FlowOCF − Capex
$-11.4M
FCF MarginFCF / Revenue
-53.6%
Capex IntensityCapex / Revenue
0.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-73.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FENC
FENC
FRGE
FRGE
Q4 25
$-6.0M
Q3 25
$1.5M
$-11.4M
Q2 25
$-3.7M
$-7.8M
Q1 25
$-4.3M
$-12.8M
Q4 24
$-1.5M
$-40.5M
Q3 24
$-2.2M
$-5.8M
Q2 24
$-8.4M
$-14.4M
Q1 24
$39.0M
$-12.4M
Free Cash Flow
FENC
FENC
FRGE
FRGE
Q4 25
Q3 25
$-11.4M
Q2 25
$-7.9M
Q1 25
$-12.9M
Q4 24
$-41.3M
Q3 24
$-6.0M
Q2 24
$-14.7M
Q1 24
$-12.8M
FCF Margin
FENC
FENC
FRGE
FRGE
Q4 25
Q3 25
-53.6%
Q2 25
-28.4%
Q1 25
-50.9%
Q4 24
-222.3%
Q3 24
-31.0%
Q2 24
-66.0%
Q1 24
-66.4%
Capex Intensity
FENC
FENC
FRGE
FRGE
Q4 25
Q3 25
0.2%
Q2 25
0.4%
Q1 25
0.2%
Q4 24
4.3%
Q3 24
0.7%
Q2 24
1.2%
Q1 24
2.1%
Cash Conversion
FENC
FENC
FRGE
FRGE
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
3.04×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FENC
FENC

Segment breakdown not available.

FRGE
FRGE

Marketplace$12.2M57%
Custodial Administration Fees$9.1M43%

Related Comparisons